<a href="https://laohu8.com/S/CATX">Perspective Therapeutics</a> Updates Executive Compensation and Change-in-Control Terms
Perspective Therapeutics Inc. has entered into amended and restated employment agreements with Chief Executive Officer Johan (Thijs) Spoor, Chief Accounting Officer Jonathan Hunt, and Chief Medical Officer Dr. Markus Puhlmann. The updated agreements set annual base salaries at $680,000 for Mr. Spoor, $451,500 for Mr. Hunt, and $516,700 for Dr. Puhlmann. In the event of termination without cause or resignation for good reason during a period beginning three months before and ending 12 months after a change in control, executives will receive severance pay equal to 12 months of salary (18 months for Mr. Spoor), a pro-rated annual bonus, an additional annual bonus payment (1.5 times for Mr. Spoor), and up to 12 months of COBRA health coverage (18 months for Mr. Spoor). The agreements also provide for accelerated vesting of equity awards under certain conditions related to a change in control.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perspective Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-262636), on November 03, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。